))
Johan Lauritsen: There needs to be a simple apply button to participate in a clinical trial
Manage episode 382347603 series 3526489
Content provided by Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
We speak to Johan Lauritsen, CEO & Founder of Probe, about how clinical trials can be an alternative to treatment.
Johan himself tried to enrol in a clinical trial for his rare chronic disease. This was an uphill battle and he never succeeded - but the experience did kindle his desire to make clinical trials available for patients.
Enrolling in a trial for a patient is not easy - even though especially chronic patients are very much willing to participate. But it is not easy for the physician to recruit patients for a clinical trial either. The problem is on both ends of the spectrum.
There is no democratic access to clinical trials for patients. Even though a patient may be eligible, they may not enrol participants who are new to trials.
Johan discusses the moral imperative of having open access to the newest treatment options for any patient fitting the criteria - wherever the trial is running in the world.
Johan also takes us through his solution for bridging the patients who are willing to participate - and the clinical sites recruiting for a clinical trial.
With the use of a simple apply button. But also by using the latest technology to ensure transparency of the use of data and security.
Guest:
Johan Lauritsen
https://www.linkedin.com/in/johanlauritsen/
PROBE
https://www.linkedin.com/company/probe-dk/
Links:
________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page
64 episodes
Share
